Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Bone marrow failure and MDS

Here you will find short summaries of selected publications regarding bone marrow failure and myelodysplastic syndrome (MDS).
Drug azacitidine safe for children with relapsed MDS or JMML (Rubio-San-Simón A, et al., 2023) Azacitidine can be safely given to children with myelodysplastic syndrome (MDS) or juvenile myelomonocytic leukemia (JMML) in whom the disease has recurred. Particularly for JMML, it also seems to work well.